5.33 USD
▲+0.13+1.91%
盘后 5.17 -1.22%
2026-08-03
市值
$320.52M
市盈率
—
EPS
-4.05
股息率
—
52 周区间
4.14 – 9.94
成交量
727.30K
Beta
0.60
目标价
14.13
52W 低 4.1452W 高 9.94
价格走势
公司简介
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion. It also develop...